메뉴 건너뛰기




Volumn 62, Issue 1, 2005, Pages 97-103

Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma

Author keywords

5 Fluorouracil; Chemoradiotherapy; Chronomodulation; Pancreatic carcinoma; Radiotherapy

Indexed keywords

CHEMOTHERAPY; DISEASES; ONCOLOGY; PATIENT TREATMENT; RADIOTHERAPY; TOXICITY;

EID: 17844385059     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.08.053     Document Type: Article
Times cited : (9)

References (37)
  • 2
    • 0021867923 scopus 로고
    • Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection
    • Gastrointestinal Tumor Study Group S.S.
    • M.H. Kalser, S.S. Ellenberg Gastrointestinal Tumor Study Group Pancreatic cancer Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899
    • (1985) Arch Surg , vol.120 , pp. 899
    • Kalser, M.H.1    Ellenberg2
  • 3
    • 0023262033 scopus 로고
    • Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
    • Gastrointestinal Tumor Study Group
    • Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 1987 2006
    • (1987) Cancer , vol.59 , pp. 2006
  • 4
    • 0021985620 scopus 로고
    • A pilot study of protracted venous infusion on 5-fluorouracil and concomitant radiation therapy
    • T.A. Rich, J.J. Lokich, J.T. Chaffey A pilot study of protracted venous infusion on 5-fluorouracil and concomitant radiation therapy J Clin Oncol 3 1985 402 406
    • (1985) J Clin Oncol , vol.3 , pp. 402-406
    • Rich, T.A.1    Lokich, J.J.2    Chaffey, J.T.3
  • 5
    • 0031963938 scopus 로고    scopus 로고
    • Chemo-radiotherapy for localized pancreatic cancer: Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil
    • J.C. Poen, H.L. Collins, J.E. Niederhuber Chemo-radiotherapy for localized pancreatic cancer Increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil Int J Radiat Oncol Biol Phys 40 1998 93 99
    • (1998) Int J Radiat Oncol Biol Phys , vol.40 , pp. 93-99
    • Poen, J.C.1    Collins, H.L.2    Niederhuber, J.E.3
  • 6
    • 0034566044 scopus 로고    scopus 로고
    • Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer
    • V.K. Mehta, G.A. Fisher, J.M. Ford Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer Int J Radiat Oncol Biol Phys 48 2000 1483 1487
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 1483-1487
    • Mehta, V.K.1    Fisher, G.A.2    Ford, J.M.3
  • 7
    • 0031717786 scopus 로고    scopus 로고
    • Adjuvant therapy for pancreatic cancer: Back to the future
    • W.F. Regine, R.A. Abrams Adjuvant therapy for pancreatic cancer Back to the future Int J Radiat Oncol Biol Phys 42 1998 59 63
    • (1998) Int J Radiat Oncol Biol Phys , vol.42 , pp. 59-63
    • Regine, W.F.1    Abrams, R.A.2
  • 8
    • 0032791920 scopus 로고    scopus 로고
    • Chemoradiation for pancreatic and biliary cancer: Current status of RTOG studies
    • R.A. Rich Chemoradiation for pancreatic and biliary cancer Current status of RTOG studies Ann Oncol 10 Suppl. 4 1999 231 233
    • (1999) Ann Oncol , vol.10 , Issue.SUPPL. 4 , pp. 231-233
    • Rich, R.A.1
  • 9
    • 0037217052 scopus 로고    scopus 로고
    • Cancer chronotherapy: Principles, applications, and perspectives
    • M.C. Mormont, F. Levi Cancer chronotherapy Principles, applications, and perspectives Cancer 97 2003 155 169
    • (2003) Cancer , vol.97 , pp. 155-169
    • Mormont, M.C.1    Levi, F.2
  • 10
    • 0027332756 scopus 로고
    • Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patient
    • G.A. Bjarnason, I.G. Kerr, N. Doyle Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patient Cancer Chemother Pharmacol 33 1993 221 228
    • (1993) Cancer Chemother Pharmacol , vol.33 , pp. 221-228
    • Bjarnason, G.A.1    Kerr, I.G.2    Doyle, N.3
  • 11
    • 0002680359 scopus 로고    scopus 로고
    • Phase II study of 5-fluorouracil and leucovorin by a 14 day chronomodulated infusion in patients with metastatic colorectal cancer
    • G.A. Bjarnason, N.M. Marsh, I. Chu Phase II study of 5-fluorouracil and leucovorin by a 14 day chronomodulated infusion in patients with metastatic colorectal cancer [Abstract] Proc Am Soc Clin Oncol 17 1998 A1158
    • (1998) Proc Am Soc Clin Oncol , vol.17 , pp. 1158
    • Bjarnason, G.A.1    Marsh, N.M.2    Chu, I.3
  • 12
    • 0035004799 scopus 로고    scopus 로고
    • Circadian expression of clock genes in human oral mucosa and skin: Association with specific cell-cycle phases
    • G.A. Bjarnason, R.C. Jordan, P.A. Wood Circadian expression of clock genes in human oral mucosa and skin Association with specific cell-cycle phases Am J Pathol 158 2001 1793 1801
    • (2001) Am J Pathol , vol.158 , pp. 1793-1801
    • Bjarnason, G.A.1    Jordan, R.C.2    Wood, P.A.3
  • 13
    • 1842569640 scopus 로고    scopus 로고
    • Final efficacy update at 7 years of flat vs chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin as first line treatment of metastatic colorectal cancer
    • F. Levi, R. Zidani, J.F. Llory Final efficacy update at 7 years of flat vs chronomodulated infusion of oxaliplatin, 5-fluorouracil and leucovorin as first line treatment of metastatic colorectal cancer [Abstract] Proc Am Soc Clin Oncol 19 2000 A936
    • (2000) Proc Am Soc Clin Oncol , vol.19 , pp. 936
    • Levi, F.1    Zidani, R.2    Llory, J.F.3
  • 14
    • 0028036652 scopus 로고
    • Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
    • F.A. Levi, R. Zidani, J.M. Vannetzel Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases A randomized multi-institutional trial J Natl Cancer Inst 86 1994 1608 1616
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1608-1616
    • Levi, F.A.1    Zidani, R.2    Vannetzel, J.M.3
  • 15
    • 0034743788 scopus 로고    scopus 로고
    • A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer
    • D.R. Penberthy, T.A. Rich, C.H. Shelton A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer Ann Oncol 12 2001 681 684
    • (2001) Ann Oncol , vol.12 , pp. 681-684
    • Penberthy, D.R.1    Rich, T.A.2    Shelton, C.H.3
  • 16
    • 0035748521 scopus 로고    scopus 로고
    • Modulation of dose intensity in aerodigestive tract cancers: Strategies to reduce toxicity
    • T.A. Rich, A.V. Kirichenko, R. Sewell Modulation of dose intensity in aerodigestive tract cancers Strategies to reduce toxicity Oncology 15 2001 1603 1622
    • (2001) Oncology , vol.15 , pp. 1603-1622
    • Rich, T.A.1    Kirichenko, A.V.2    Sewell, R.3
  • 17
    • 0031056942 scopus 로고    scopus 로고
    • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
    • F.R. Spitz, J.L. Abbruzzese, J.E. Lee Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 1997 928 937
    • (1997) J Clin Oncol , vol.15 , pp. 928-937
    • Spitz, F.R.1    Abbruzzese, J.L.2    Lee, J.E.3
  • 18
    • 17544392986 scopus 로고    scopus 로고
    • Combined radiotherapy and chemotherapy (cisplatin and 5-FU) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study
    • T. Andre, J. Balosso, C. Louvet Combined radiotherapy and chemotherapy (cisplatin and 5-FU) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma Results of a feasibility study Int J Radiat Oncol Biol Phys 46 2000 903 911
    • (2000) Int J Radiat Oncol Biol Phys , vol.46 , pp. 903-911
    • Andre, T.1    Balosso, J.2    Louvet, C.3
  • 19
    • 0034333248 scopus 로고    scopus 로고
    • Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: Acceptable toxicity and suggestion of improved 1-year disease-free survival
    • A. Chakravarthy, R.A. Abrams, C.J. Yeo Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma Acceptable toxicity and suggestion of improved 1-year disease-free survival Int J Radiat Oncol Biol Phys 48 2000 1089 1096
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , pp. 1089-1096
    • Chakravarthy, A.1    Abrams, R.A.2    Yeo, C.J.3
  • 20
    • 0035917952 scopus 로고    scopus 로고
    • Gemcitabine following radiotherapy with concurrent 5-FU for nonmetastatic adenocarcinoma of the pancreas
    • L.A. Kachnic, J.E. Shaw, M.A. Manning Gemcitabine following radiotherapy with concurrent 5-FU for nonmetastatic adenocarcinoma of the pancreas Int J Cancer 96 2001 132 139
    • (2001) Int J Cancer , vol.96 , pp. 132-139
    • Kachnic, L.A.1    Shaw, J.E.2    Manning, M.A.3
  • 21
    • 0032784821 scopus 로고    scopus 로고
    • Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA 19-9 levels
    • R.A. Abrams, L.B. Grochow, A. Chakravarthy Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma Survival results and observations regarding patterns of failure, radiotherapy dose and CA 19-9 levels Int J Radiat Oncol Biol Phys 44 1999 1039 1046
    • (1999) Int J Radiat Oncol Biol Phys , vol.44 , pp. 1039-1046
    • Abrams, R.A.1    Grochow, L.B.2    Chakravarthy, A.3
  • 22
    • 0035841631 scopus 로고    scopus 로고
    • Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomized controlled trial
    • J.P. Neoptolemos, J.A. Dunn, D.D. Stocken Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer A randomized controlled trial Lancet 358 2001 1576 1585
    • (2001) Lancet , vol.358 , pp. 1576-1585
    • Neoptolemos, J.P.1    Dunn, J.A.2    Stocken, D.D.3
  • 23
    • 0034656872 scopus 로고    scopus 로고
    • Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
    • Y. Nukui, V.J. Picozzi, L.W. Traverso Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 179 2000 367 371
    • (2000) Am J Surg , vol.179 , pp. 367-371
    • Nukui, Y.1    Picozzi, V.J.2    Traverso, L.W.3
  • 24
    • 0037406666 scopus 로고    scopus 로고
    • Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma
    • V.J. Picozzi, R.A. Kozarek, L.W. Traverso Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 185 2003 476 480
    • (2003) Am J Surg , vol.185 , pp. 476-480
    • Picozzi, V.J.1    Kozarek, R.A.2    Traverso, L.W.3
  • 25
    • 0033655559 scopus 로고    scopus 로고
    • The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma
    • W.F. Regine, W.J. John, P. McGrath The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma J Hepatobiliary Pancreat Surg 7 2000 53 57
    • (2000) J Hepatobiliary Pancreat Surg , vol.7 , pp. 53-57
    • Regine, W.F.1    John, W.J.2    McGrath, P.3
  • 26
    • 0029871288 scopus 로고    scopus 로고
    • Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy
    • M.A. Carducci, R.A. Abrams, C.J. Yeo Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy Int J Radiat Oncol Biol Phys 35 1996 143 150
    • (1996) Int J Radiat Oncol Biol Phys , vol.35 , pp. 143-150
    • Carducci, M.A.1    Abrams, R.A.2    Yeo, C.J.3
  • 27
    • 0036285897 scopus 로고    scopus 로고
    • Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy--A survey of 427 patients
    • N. Tsavaris, C. Kosmas, M. Vadiaka Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy--A survey of 427 patients Med Sci Monit 8 2002 PI51-P157
    • (2002) Med Sci Monit , vol.8
    • Tsavaris, N.1    Kosmas, C.2    Vadiaka, M.3
  • 28
    • 8244254377 scopus 로고    scopus 로고
    • Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer: A randomized trial
    • H.A. Burris, M.J. Moore, J. Anderson Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreas cancer A randomized trial J Clin Oncol 15 1997 2403 2413
    • (1997) J Clin Oncol , vol.15 , pp. 2403-2413
    • Burris, H.A.1    Moore, M.J.2    Anderson, J.3
  • 29
    • 0028292341 scopus 로고
    • Phase II trial of gemcitabine (2′2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
    • E.S. Casper, M.R. Green, D.P. Kelsen Phase II trial of gemcitabine (2′2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas Invest New Drugs 12 1994 29 34
    • (1994) Invest New Drugs , vol.12 , pp. 29-34
    • Casper, E.S.1    Green, M.R.2    Kelsen, D.P.3
  • 30
    • 0000046403 scopus 로고    scopus 로고
    • A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer
    • C. McGinn, D. Smith, C. Szarka A phase I study of gemcitabine in combination with radiation therapy in patients with localized, unresectable pancreatic cancer [Abstract] Proc Am Soc Clin Oncol 17 1998 264a
    • (1998) Proc Am Soc Clin Oncol , vol.17
    • McGinn, C.1    Smith, D.2    Szarka, C.3
  • 31
    • 0000643645 scopus 로고    scopus 로고
    • A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine in patients with localized, resectable pancreatic adenocarcinoma
    • J. Hoffman, C.J. McGinn, C. Szarka A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine in patients with localized, resectable pancreatic adenocarcinoma [Abstract] Proc Am Soc Clin Oncol 17 1998 283a
    • (1998) Proc Am Soc Clin Oncol , vol.17
    • Hoffman, J.1    McGinn, C.J.2    Szarka, C.3
  • 32
    • 0034880820 scopus 로고    scopus 로고
    • Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma
    • R.A. Wolff, D.B. Evans, D.M. Gravel Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma Clin Cancer Res 7 2001 2246 2253
    • (2001) Clin Cancer Res , vol.7 , pp. 2246-2253
    • Wolff, R.A.1    Evans, D.B.2    Gravel, D.M.3
  • 33
    • 0038460691 scopus 로고    scopus 로고
    • Radiation therapy with once weekly gemcitabine in pancreatic cancer: Current status of clinical trials
    • C.J. McGinn, M.M. Zalupski Radiation therapy with once weekly gemcitabine in pancreatic cancer Current status of clinical trials Int J Radiat Oncol Biol Phys 56 4 Suppl. 2003 10 15
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , Issue.4 SUPPL. , pp. 10-15
    • McGinn, C.J.1    Zalupski, M.M.2
  • 34
    • 0035890443 scopus 로고    scopus 로고
    • Phase I Trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer
    • C.J. McGinn, M.M. Zalupski, I. Shureiqi Phase I Trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer J Clin Oncol 19 2001 4202 4208
    • (2001) J Clin Oncol , vol.19 , pp. 4202-4208
    • McGinn, C.J.1    Zalupski, M.M.2    Shureiqi, I.3
  • 35
    • 0036534672 scopus 로고    scopus 로고
    • Is the therapeutic index better with gemcitabine based chemoradiation than with 5-fluorouracil based chemoradiation in locally advanced pancreatic cancer?
    • C.H. Crane, J.L. Abbruzzese, D.B. Evens Is the therapeutic index better with gemcitabine based chemoradiation than with 5-fluorouracil based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 2002 1293 1302
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 1293-1302
    • Crane, C.H.1    Abbruzzese, J.L.2    Evens, D.B.3
  • 36
    • 0029681983 scopus 로고    scopus 로고
    • Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy
    • R.W. Marsh, N.M. Chu, J.N. Vauthey Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy Cancer 78 1996 217 225
    • (1996) Cancer , vol.78 , pp. 217-225
    • Marsh, R.W.1    Chu, N.M.2    Vauthey, J.N.3
  • 37
    • 2942648695 scopus 로고    scopus 로고
    • Four decades of continuing innovation with fluorouracil: Concurrent and future approaches to fluorouracil chemoradiation therapy
    • T.A. Rich, R.C. Shepard, S.T. Mosley Four decades of continuing innovation with fluorouracil Concurrent and future approaches to fluorouracil chemoradiation therapy J Clin Oncol 22 2004 2214 2232
    • (2004) J Clin Oncol , vol.22 , pp. 2214-2232
    • Rich, T.A.1    Shepard, R.C.2    Mosley, S.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.